Gastric and Intestinal Absorption of Captopril in Acutely and Chronically Treated Rats: Comparison with Salicylic Acid
- 1 December 1984
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 73 (12), 1755-1758
- https://doi.org/10.1002/jps.2600731224
Abstract
The gastric and intestinal absorption of captopril, an orally active angiotensin-converting enzyme inhibitor [antihypertensive agent] was determined using rat in situ gastric pouch and intestinal loop techniques and compared with the absorption of another acidic drug, salicyclic acid, whose absorption has been well established from both gastric and intestinal sites. Captopril absorption was determined at 2 initial intraluminal concentrations in acute (untreated) rats and in rats that had been treated with captopril. Salicyclic acid absorption was determined at 1 concentration in acute rats. During the 40-min experimental period, captopril absorption at the 4.6 mM dose from the gastric pouch was 17.0 .+-. 1.8% and 17.9 .+-. 5.4% in acute and chronically treated rats, respectively, and 33.6 .+-. 9.2% and 23.7 .+-. 7.6%, respectively, from the intestinal loop. At the 11.5 mM dose the captopril absorption in 40 min was 13.7 .+-. 2.7% and 17.3 .+-. 4.2% from the gastric pouch of acutely and chronically treated rats, respectively, and 17.8 .+-. 4.2% and 22.9 .+-. 3.3%, respectively, from the intestinal loop. As similar fractions of the different administered doses were absorbed from the respective gastric and intestinal sites in both acutely and chronically treated rats, the absorption process of captopril appears to be principally by passive diffusion and unaffected by chronic administration of captopril. In comparison salicylic acid was absorbed more rapidly and to a greater extent from both the gastric and intestinal preparations. The percent of salicyclic acid absorbed into the plasma at the 11.5 mM dose was 44.8 .+-. 4.4% and 65.3 .+-. 5.3% from the gastric and intestinal preparations, respectively. Gastric absorption of captopril evidently does occur, but its relative importance to intestinal absorption is dependent on the transit time from the gastric to intestinal site.This publication has 20 references indexed in Scilit:
- An in situ gastric pouch technique for direct measurement of the gastric absorption of drugs in the ratJournal of Pharmacological Methods, 1983
- Tissue distribution of captopril, reducible captopril conjugates and S-methylcaptopril in the ratBiochemical Pharmacology, 1983
- Determination of Captopril in Human Blood and Urine by GLC-Selected Ion Monitoring Mass Spectrometry after Oral Coadministration with Its IsotopomerJournal of Pharmaceutical Sciences, 1982
- Drug protein conjugates—I. A study of the covalent binding of [14C]captopril to plasma proteins in the ratBiochemical Pharmacology, 1982
- Pharmacokinetic properties of captopril after acute and chronic administration to hypertensive subjectsThe American Journal of Cardiology, 1982
- Angiotensin Converting Enzyme (ACE) InhibitorsAnnual Review of Pharmacology and Toxicology, 1982
- Captopril kineticsClinical Pharmacology & Therapeutics, 1982
- Effect of Food on the Bioavailability of Captopril in Healthy SubjectsThe Journal of Clinical Pharmacology, 1982
- In vitro studies on the metabolic pathway of SQ 14225 (captopril) and mechanism of mixed disulfide formation.Journal of Pharmacobio-Dynamics, 1981
- On the Mechanism of Absorption of Drugs from the Gastrointestinal TractJournal of Medicinal Chemistry, 1960